These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9667107)

  • 1. Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol.
    Hamanaka H; Mizutani H; Nouchi N; Shimizu Y; Shimizu M
    Clin Exp Dermatol; 1998 Jan; 23(1):32-4. PubMed ID: 9667107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic reaction to allopurinol with cross-reactivity to oxypurinol.
    Lockard O; Harmon C; Nolph K; Irvin W
    Ann Intern Med; 1976 Sep; 85(3):333-5. PubMed ID: 134655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oxypurinol concentration in a patient with allopurinol hypersensitivity.
    Puig JG; Casas EA; Ramos TH; Michán AA; Mateos FA
    J Rheumatol; 1989 Jun; 16(6):842-4. PubMed ID: 2528636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.
    Yun J; Mattsson J; Schnyder K; Fontana S; Largiadèr CR; Pichler WJ; Yerly D
    Clin Exp Allergy; 2013 Nov; 43(11):1246-55. PubMed ID: 24152157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the specificity of allopurinol and oxypurinol as inhibitors of xanthine oxidase. A pulse radiolysis determination of rate constants for reaction of allopurinol and oxypurinol with hydroxyl radicals.
    Hoey BM; Butler J; Halliwell B
    Free Radic Res Commun; 1988; 4(4):259-63. PubMed ID: 2852627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical.
    Spector T
    Biochem Pharmacol; 1988 Jan; 37(2):349-52. PubMed ID: 2829916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates.
    Chu WY; Annink KV; Nijstad AL; Maiwald CA; Schroth M; Bakkali LE; van Bel F; Benders MJNL; van Weissenbruch MM; Hagen A; Franz AR; Dorlo TPC; Allegaert K; Huitema ADR;
    Clin Pharmacokinet; 2022 Feb; 61(2):321-333. PubMed ID: 34617261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The allopurinol hypersensitivity syndrome: its relation to plasma oxypurinol levels.
    Casas E; Puig JG; Mateos FA; Jiménez ML; Michán AD; Ramos TH
    Adv Exp Med Biol; 1989; 253A():257-60. PubMed ID: 2624201
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.
    Stamp LK; Taylor WJ; Jones PB; Dockerty JL; Drake J; Frampton C; Dalbeth N
    Arthritis Rheum; 2012 Aug; 64(8):2529-36. PubMed ID: 22488501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide radical production by allopurinol and xanthine oxidase.
    Galbusera C; Orth P; Fedida D; Spector T
    Biochem Pharmacol; 2006 Jun; 71(12):1747-52. PubMed ID: 16650385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.
    Chung WH; Pan RY; Chu MT; Chin SW; Huang YL; Wang WC; Chang JY; Hung SI
    J Invest Dermatol; 2015 Sep; 135(9):2237-2248. PubMed ID: 25946710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
    McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
    Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage.
    Das DK; Engelman RM; Clement R; Otani H; Prasad MR; Rao PS
    Biochem Biophys Res Commun; 1987 Oct; 148(1):314-9. PubMed ID: 2823807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol hypersensitivity: investigating the cause and minimizing the risk.
    Stamp LK; Day RO; Yun J
    Nat Rev Rheumatol; 2016 Apr; 12(4):235-42. PubMed ID: 26416594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxipurinol: alloxanthine, Oxyprim, oxypurinol.
    Drugs R D; 2004; 5(3):171-5. PubMed ID: 15139781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
    Graham S; Day RO; Wong H; McLachlan AJ; Bergendal L; Miners JO; Birkett DJ
    Br J Clin Pharmacol; 1996 Apr; 41(4):299-304. PubMed ID: 8730975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics or oral and intravenous allopurinol and intravenous oxypurinol in the horse.
    Mills PC; Dunnett M; Smith NC
    J Vet Pharmacol Ther; 1995 Dec; 18(6):451-6. PubMed ID: 8789699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of furosemide on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.